# Exegenesis Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/exegenesis-bio

- Industry: Biotechnology
- Headquarters: US
- Total disclosed funding: $30M
- Latest round: Series B (Aug 4, 2020)
- Investors on record: 6

## About

Founded in 2019 and based in Pennsylvania, US, Exegenesis Bio Inc. operates as a medical health company that develops and manufacture gene therapy drugs.

## Funding rounds

- Series B, Aug 4, 2020, $20M — Legend Holdings, Kaitai Capital, K2VC, TF Capital, BioTrack Capital
- Series A, Oct 1, 2019, $10M — Kaitai Capital, Legend Star, K2VC

## Investors

- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Series A, Series B
- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series A
- K2VC (https://capitalatlas.ai/funds/k2vc) — Series A, Series B
- Legend Holdings — Series B
- TF Capital — Series B
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series B